References
- Akram D.S., Igarashi A., Takasu T.: Dengue virus infection among children with undifferentiated fever in Karachi. Indian J Pediatr 1998, 65, 735–740.
- Bartelma G., Padmanabhan R.: Expression, Purification, and Characterization of the RNA 5′-triphosphatase activity of dengue virus type 2 nonstructural protein 3. Virology 2002, 299, 122–132.
- Bhatt S., Gething P.W., Brady O.J., Messina J.P., Farlow A.W., Hay S.I.: The global distribution and burden of dengue. Nature 2013, 496, 504–507.
- Chan Y.C., Salahuddin N.I., Khan J., Tan H.C., Seah C.L.K., Chow V.T.K.: Dengue haemorrhagic fever outbreak in Karachi, Pakistan, 1994. Trans R Soc Trop Med Hyg 1995, 89, 619–620.
- Clum S., Ebner K.E., Padmanabhan R.: Cotranslational membrane insertion of the serine proteinase precursor NS2B-NS3(Pro) of dengue virus type 2 is required for efficient in vitro processing and is mediated through the hydrophobic regions of NS2B. J Biol Chem United States; 1997, 272, 30715–30723.
- Das S., Pingle M.R., Muñoz-Jordán J., Rundell M.S., Rondini S., Golightly L.M.: Detection and serotyping of dengue virus in serum samples by multiplex reverse transcriptase PCR-ligase detection reaction assay. J Clin Microbiol 2008, 46, 3276–3284.
- Falgout B., Miller R.H., Lai C.J.: Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity. J Virol 1993, 67, 2034–2042.
- Fatima Z., Idrees M., Bajwa M.A., Tahir Z., Ullah O., Ali M.: Serotype and genotype analysis of dengue virus by sequencing followed by phylogenetic analysis using samples from three mini outbreaks-2007–2009 in Pakistan. BMC Microbiol 2011, 11, 200.
- Gibbons R.V., Vaughn D.W.: Dengue: an escalating problem. BMJ England 2002, 324, 1563–1566.
- Gubler D.J.: Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998, 11, 480–496.
- Jahan F.: Dengue fever (DF) in Pakistan. Asia Pac Fam Med 2011, 10, 1-4.
- Keller T.H., Chen Y.L., Knox J.E., Lim S.P., Ma N.L., Patel S.J., Sampath A., Wang Q.Y., Yin Z., Vasudevan S.G.: Finding new medicines for flaviviral targets. Novartis Found Symp 2006, 277, 102–114.
- Khan E., Hasan R., Mehraj V., Nasir A., Siddiqui J., Hewson R.: Co-circulations of two genotypes of dengue virus in 2006 outbreak of dengue hemorrhagic fever in Karachi, Pakistan. J Clin Virol 2008, 43, 176–179.
- Khan E., Kisat M., Khan N., Nasir A., Ayub S., Hasan R.: Demographic and clinical features of dengue fever in Pakistan from 2003–2007: A retrospective cross-sectional study. PLoS One 2010, 5, 1–7.
- Leardkamolkarn V., Sirigulpanit W., Phurimsak C., Kumkate S., Himakoun L., Sripanidkulchai B.: The inhibitory actions of houttuynia cordata aqueous extract on dengue virus and dengue-infected cells. J Food Biochem 2012, 36, 86–92.
- Lescar J., Luo D., Xu T., Sampath A., Lim S.P., Vasudevan S.G.: Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target. Antiviral Res 2008, 5, 94–101.
- Libraty D.H., Young P.R., Pickering D., Endy T.P., Kalayanarooj S., Rothman A.L.: High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis 2002, 186, 1165–1168.
- Lindenbach B.D., Prágai B.M., Montserret R., Beran R.K.F., Pyle A.M., Rice C.M.: The C terminus of hepatitis C virus NS4A encodes an electrostatic switch that regulates NS5A hyperphosphorylation and viral replication. J Virol 2007, 81, 8905–8918.
- Natarajan S.: NS3 protease from flavivirus as a target for designing antiviral inhibitors against dengue virus. Genet Mol Biol Ribeirão Preto SP Brazil 2010, 2, 214–219.
- Rai M.A.: Epidemic: control of dengue fever in Pakistan. Nature 2011, 479, 40-41.
- Sambrook J., Russell D.W.: The inoue method for preparation and transformation of competent E. coli “ultra-competent” cells. http://cshprotocols.org/lookup/doi/10.1101/pdb.prot3944.
- Shum D., Smith J.L., Hirsch A.J., Bhinder B., Radu C., Stein D.A., Nelson J.A., Fruh K., Djaballah H.: High-content assay to identify inhibitors of dengue virus infection. Assay Drug Develop Technol 2010, 8, 553–570.
- Wilder-Smith A., Ooi E.E., Vasudevan S.G., Gubler D.J.: Update on dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development. Curr Infect Dis Rep 2010, 12, 157–164.